Company / AR per Share
Charles River Laboratories AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$14.40
FY2025
5-year range
$12.92 / $15.32
FY2021-FY2025
Trend
+2.6%
vs FY2024
Sector context
#14 of 136
Health Care
What the data says
Among 136 Health Care companies, Charles River Laboratories is in the top 10% for ar per share. Declined from $15.32 to $14.40 over the past 2 years.
Based on SEC 10-K filings.
14.40 in FY2025 with a 5-year CAGR of +2.7%. Top quartile in the Health Care sector.
Declined from $15.32 to $14.40 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -1.1%
- 5-Year CAGR
- +2.7%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 136This company $14.40 Sector average $12.09
▼
+19.1% above sector average
Key checks
Key Insights
- In FY2025, ar per share increased 2.6% year-over-year.
- Ranks #14 out of 136 companies in the Health Care sector.
- Peak ar per share was recorded in FY2023.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.40 | +2.6% |
| FY2024 | $14.04 | -8.3% |
| FY2023 | $15.32 | +2.8% |
| FY2022 | $14.90 | +15.4% |
| FY2021 | $12.92 | +2.3% |
| FY2020 | $12.62 | +18.4% |
| FY2019 | $10.66 | +7.0% |
| FY2018 | $9.96 | +9.7% |
| FY2017 | $9.08 | +16.5% |
| FY2016 | $7.80 | +36.6% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026